GLP-1 receptor agonist-related risk of pancreatic cancer

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2023年 / 1951卷 / 1期
关键词：
D O I：
10.1007/s40278-023-36789-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：12 / 12
相关论文
共 50 条
  • [21] The GLP-1 receptor agonist revolution comes to nephrology
    Thomas, Merlin C.
    Cooper, Mark E.
    NATURE REVIEWS NEPHROLOGY, 2024, 20 (10) : 637 - 638
  • [22] Insights into GLP-1 Receptor Activation with a Nonpeptide Agonist
    Martinez, Thomas F.
    Vaughan, Joan
    Saghatelian, Alan
    BIOCHEMISTRY, 2020, 59 (16) : 1549 - 1550
  • [23] Clinical Pharmacology of Albiglutide, a GLP-1 Receptor Agonist
    Young, Malcolm A.
    Wald, Jeffrey A.
    Matthews, Jessica E.
    Scott, Rhona
    Hodge, Rebecca J.
    Zhi, Hui
    Reinhardt, Rickey R.
    POSTGRADUATE MEDICINE, 2014, 126 (07) : 84 - 97
  • [24] Risk of thyroid cancer with the use of GLP-1 receptor agonists
    Gouverneur, Amandine
    Penichon, Marine
    Garrel, Renaud
    Hillaire-Buys, Dominique
    Pariente, Antoine
    Faillie, Jean-Luc
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 330 - 330
  • [25] The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor
    Nishizawa, M
    Nakabayashi, H
    Kawai, K
    Ito, T
    Kawakami, S
    Nakagawa, A
    Niijima, A
    Uchida, K
    JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 2000, 80 (1-2): : 14 - 21
  • [26] Ex Vivo Imaging of Pancreatic Beta Cells using a Radiolabeled GLP-1 Receptor Agonist
    Brett M. Connolly
    Amy Vanko
    Paul McQuade
    Ilonka Guenther
    Xiangjun Meng
    Daniel Rubins
    Rikki Waterhouse
    Richard Hargreaves
    Cyrille Sur
    Eric Hostetler
    Molecular Imaging and Biology, 2012, 14 : 79 - 87
  • [27] Ex Vivo Imaging of Pancreatic Beta Cells using a Radiolabeled GLP-1 Receptor Agonist
    Connolly, Brett M.
    Vanko, Amy
    McQuade, Paul
    Guenther, Ilonka
    Meng, Xiangjun
    Rubins, Daniel
    Waterhouse, Rikki
    Hargreaves, Richard
    Sur, Cyrille
    Hostetler, Eric
    MOLECULAR IMAGING AND BIOLOGY, 2012, 14 (01) : 79 - 87
  • [28] GLP-1 receptor agonist-based therapies and cardiovascular risk: a review of mechanisms
    Mullur, Neerav
    Morissette, Arianne
    Morrow, Nadya M.
    Mulvihill, Erin E.
    JOURNAL OF ENDOCRINOLOGY, 2024, 263 (01)
  • [29] GLP-1 and dual GIP/GLP-1 receptor agonists increase risk of aspiration
    Reactions Weekly, 2025, 2044 (1) : 3 - 3
  • [30] GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
    Zhao, Xin
    Wang, Minghe
    Wen, Zhitong
    Lu, Zhihong
    Cui, Lijuan
    Fu, Chao
    Xue, Huan
    Liu, Yunfeng
    Zhang, Yi
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
12345